ANUHPHR — Anuh Pharma Share Price
0.000.00%
Last trade - 00:00- IN₹8.59bn
- IN₹8.20bn
- IN₹6.47bn
- 82
- 29
- 41
- 51
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.83 | ||
| Price to Tang. Book | 2.83 | ||
| Price to Free Cashflow | 392.05 | ||
| Price to Sales | 1.37 | ||
| EV to EBITDA | 13.35 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 17.47% | ||
| Return on Equity | 17.95% | ||
| Operating Margin | 8.49% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 3,069.6 | 4,319.6 | 4,866.46 | 5,274.86 | 6,470.04 | n/a | n/a | 15.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -38.75 | +98.78 | +7.3 | +18.53 | +66.1 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Anuh Pharma Limited is engaged in the business of manufacturing and selling bulk drugs and chemicals. The Company's products include active pharmaceutical ingredients and corticosteroids. Its active pharmaceutical ingredients include macrolides, anti-TB, anti-malarial, antibacterial, anti-hypertension, expectorant, quinolones, intermediates and under development. Its macrolides products include erythromycin, erythromycin ethyl succinate, erythromycin stearate, erythromycin estolate, erythromycin propionate, erythromycin phosphate, and others. Its anti-malarial products include sulfadoxine, pyrimethamine, and others. The Company's anti-hypertension products include losartan potassium, telmisartan and atorvastatin calcium. The Company's corticosteroids include anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic, antihistamines and under development. Its anti-inflammatory products include dexamethasone Na phosphate, mometasone furoate and clobetasol butyrate.
Directors
- Bipin Shah NVC
- Bharat Gangani CCO
- Ritesh Bipin Shah MDR
- Vivek Shah MDR
- Ketan Shah DRC
- Samir Shah DRC
- Bharat Shah NED (66)
- Lalitkumar Shah NED
- Mita Dixit NID
- Sandeep Joshi NID
- Harmanbhai Patel NID
- Jasvantlal Shah NID
- Arun Todarwal NID (63)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 19th, 1960
- Public Since
- April 19th, 1995
- No. of Shareholders
- 22,677
- No. of Employees
- 175
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 50,112,000
- Address
- E - 17/3 & 17/4, MUMBAI, 400018
- Web
- https://www.anuhpharma.com/
- Phone
- +91 2266227575
- Auditors
- Jayantilal Thakkar & Co.
Upcoming Events for ANUHPHR
Q1 2026 Anuh Pharma Ltd Earnings Release
Anuh Pharma Ltd Annual Shareholders Meeting
Similar to ANUHPHR
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Anuh Pharma share price?
As of Today at 19:17 UTC, shares in Anuh Pharma are trading at IN₹171.34. This share price information is delayed by 15 minutes.
How has the Anuh Pharma share price performed this year?
Shares in Anuh Pharma last closed at IN₹171.34 and the price had moved by over the past 365 days. In terms of relative price strength the Anuh Pharma share price has matched the S&P BSE 100 Index by over the past year.
What are the analyst and broker recommendations for Anuh Pharma?
There is no consensus recommendation for this security.
Find out moreWhat is the Anuh Pharma dividend yield?
The Anuh Pharma dividend yield is 1.46% based on the trailing twelve month period.
Does Anuh Pharma pay a dividend?
Last year, Anuh Pharma paid a total dividend of IN₹2.50, and it currently has a trailing dividend yield of 1.46%. We do not have any data on when Anuh Pharma is to next pay dividends.
When does Anuh Pharma next pay dividends?
We do not have data on when Anuh Pharma is to next pay dividends. The historic dividend yield on Anuh Pharma shares is currently 1.46%.
How do I buy Anuh Pharma shares?
To buy shares in Anuh Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Anuh Pharma?
As of the previous close price of IN₹171.34, shares in Anuh Pharma had a market capitalisation of IN₹8.59bn.
Where are Anuh Pharma shares listed?
Here are the trading details for Anuh Pharma:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ANUHPHR
What kind of share is Anuh Pharma?
Based on an overall assessment of its quality, value and momentum Anuh Pharma is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Anuh Pharma share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Anuh Pharma share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Anuh Pharma. Over the past six months, its share price has matched the S&P BSE 100 Index by .
As of the last closing price of IN₹171.34, shares in Anuh Pharma were trading -6.7% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Anuh Pharma PE Ratio?
The Anuh Pharma PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹171.34.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Anuh Pharma?
Anuh Pharma's management team is headed by:
- Bipin Shah - NVC
- Bharat Gangani - CCO
- Ritesh Bipin Shah - MDR
- Vivek Shah - MDR
- Ketan Shah - DRC
- Samir Shah - DRC
- Bharat Shah - NED
- Lalitkumar Shah - NED
- Mita Dixit - NID
- Sandeep Joshi - NID
- Harmanbhai Patel - NID
- Jasvantlal Shah - NID
- Arun Todarwal - NID